 <h1>Levobetaxolol ophthalmic Side Effects</h1><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Interactions</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p><i>Applies to levobetaxolol ophthalmic: ophthalmic suspension</i></p><h3>General</h3><p>Although systemic adverse events have been only infrequently reported, levobetaxolol ophthalmic drops may be absorbed systemically and side effects similar to systemically administered beta-blockers such as severe respiratory or cardiac reactions have been experienced.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Cardiovascular side effects have included bradycardia, heart block, hypotension, hypertension, tachycardia, and vascular anomaly in less than 2% of patients.<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Respiratory side effects have been related to the ability of levobetaxolol to inhibit bronchodilation, which may be important in some patients with reversible airway disease, including asthma or severe obstructive lung disease.  Asthmatic attacks, bronchospasm, pulmonary distress, bronchitis, dyspnea, pharyngitis, pneumonia, rhinitis, and sinusitis have been reported.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Gastrointestinal side effects have included  constipation and dyspepsia in less than 2% of patients.<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Endocrine side effects have included diabetes and hypothyroidism in less than 2% of patients, and thyrotoxicosis.<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Metabolic side effects have included gout, hypercholesterolemia, and hyperlipidemia in less than 2% of patients.<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Musculoskeletal side effects have included arthritis, tendonitis, and exacerbation of myasthenia gravis in less than 2% of patients.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Dermatologic side effects have included alopecia, dermatitis, and psoriasis in less than 2% of patients.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Nervous system side effects have included dizziness, anxiety, hypertonia, and vertigo in less than 2% of patients.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Genitourinary side effects have included breast abscess and cystitis in less than 2% of patients.<sup>[Ref]</sup></p><h3>Other</h3><p>Other side effects that have been attributed to levobetaxolol ophthalmic have included accidental injury, ear pain, otitis media, tinnitus, and infection in less than 2% of patients.<sup>[Ref]</sup></p><h3>Ocular</h3><p>Ocular side effects have included transient discomfort and pain after instillation (11%), transient blurred vision (2%), cataracts (&lt;2%), and vitreous disorders (&lt;2%).<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Betaxon (levobetaxolol ophthalmic)" Alza, Palo Alto, CA. </p><h2>More about levobetaxolol ophthalmic</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: ophthalmic glaucoma agents</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Glaucoma, Open Angle</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>